Eisai Resubmits Aricept sNDA For Severe Alzheimer’s
This article was originally published in The Pink Sheet Daily
Executive Summary
Eisai has submitted a reformatted electronic supplemental new drug application for Aricept (donepezil), the firm announced Dec. 19